China, India On Verge Of Making Generics Of Key Biotech Drugs
This article was originally published in PharmAsia News
Executive Summary
China and India appear to be on the threshold of developing generic copies of the biotechnology drugs increasingly used to treat cancer, diabetes and other diseases formerly associated with rich countries